Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome-Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA Network.

Of note, despite the highly significant decrease in the number of disease flares, whose median frequency was at most about an attack per year after biologic treatment, the start of biologic agents did not necessarily bring about a complete suppression of TRAPS exacerbations always and in any case.

also in 132,142 other papers